BAUDETTE, Minn., Oct. 26, 2017 /PRNewswire/ -- ANI
Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the
Company plans to release its third quarter and year-to-date 2017
financial results on Thursday, November 2,
2017, before the opening of the U.S. financial markets. The
earnings press release will be accessible through the Investor
Relations section of the Company's website,
www.anipharmaceuticals.com.
Arthur S. Przybyl, President and
Chief Executive Officer, and Stephen P.
Carey, Vice President, Finance, and Chief Financial Officer,
also plan to host a conference call to review those results
starting at 10:30am Eastern Time on
Thursday, November 2, 2017. The call
will be open to the public and can be accessed through a conference
line by dialing (866) 776-8875. The conference ID is 95990267.
A recording of the conference call will be available within two
hours of the completion of the call and will remain accessible for
a period of seven days following the call. To access the replay,
dial (800) 585-8367. The access code for the replay is
95990267.
About ANI
ANI Pharmaceuticals, Inc. (the "Company" or "ANI") is an
integrated specialty pharmaceutical company focused on delivering
value to our customers by developing, manufacturing, and marketing
high quality branded and generic prescription pharmaceuticals. The
Company's targeted areas of product development currently include
controlled substances, oncolytics (anti-cancers), hormones and
steroids, and complex formulations involving extended release and
combination products. For more information, please visit our
website www.anipharmaceuticals.com.
For more information about ANI, please contact:
Investor Relations
IR@anipharmaceuticals.com
View original
content:http://www.prnewswire.com/news-releases/ani-pharmaceuticals-schedules-conference-call-to-discuss-third-quarter-and-year-to-date-2017-financial-results-300543196.html
SOURCE ANI Pharmaceuticals, Inc.